On Tuesday, US Representative Steve Stivers (Republican, Ohio) and Representative Bill Foster (Democrat, Illinois) introduced HR 5340, the Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patent Act, in order to strengthen the USA’s crippled patent system.
The STRONGER Patent Act would reverse that trend by standing up for small businesses that rely on patents by providing court-level standards at the United States Patents and Trademark Office and providing injunctive relief against those who infringe on patents. It also protects small patent owners and start-ups by eliminating harassing, duplicitous patent demand letters, many of which are often sent in bad faith by so-called “trolls.” By defining the process of sending superfluous demand letters as a “Deceptive and Unfair Act or Practice,” the STRONGER Patent Act is equipping the Federal Trade Commission (FTC) with the tools necessary to crack down on these trolls.
Welcomed by biotech trade group
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze